Company Highnoon Laboratories Limited

HINOON

PK0070701013

Pharmaceuticals

End-of-day quote Pakistan S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
701.10 ^PKR	+0.16%		-0.41%	+38.95%

Aug. 29	Highnoon Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
Jul. 22	Highnoon Laboratories Limited Announces Executive Changes	CI

Business description: Highnoon Laboratories Limited

Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology product include Hitase. Its pediatrics product include Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology product include Prostam.

Number of employees: 2,295

Sales by Activity: Highnoon Laboratories Limited

Fiscal Period: December	2019	2020	2021	2022	2023
Pharmaceuticals	9.05B	10.7B	13B	15.82B	19.77B

See all business segments

Geographical breakdown of sales: Highnoon Laboratories Limited

Fiscal Period: December	2019	2020	2021	2022	2023
Pakistan	8.55B	10.14B	12.43B	14.93B	18.57B
Afghanistan	-	343M	296M	589M	750M
United Arab Emirates	-	83.91M	106M	103M	143M
France	-	68.12M	68.12M	49.71M	81.53M
Dubai	-	-	-	19.89M	78.48M
Iraq	-	-	14.37M	61.12M	45.08M
Tanzania	-	7.95M	3.91M	21.09M	39.03M
Sudan	-	-	-	-	22.1M
Kenya	-	26.19M	64.63M	15.37M	20.53M
Cambodia	-	18.75M	6.87M	18.25M	15.84M
Others	-	7.64M	5.71M	11.44M	4.64M
Unallocated	104M	-	-	-	-
Export	394M	-	-	-	-

See all geographic segments

Managers: Highnoon Laboratories Limited

Director	Title	Age	Since
Adeel Abbas Haideri CEO	Chief Executive Officer	-	-
Ashfaq P. Alidina DFI	Director of Finance/CFO	-	20-03-31
Ali Sarwar CTO	Chief Tech/Sci/R&D Officer	-	-
Ahmad Raza CTO	Chief Tech/Sci/R&D Officer	-	-
Sajjad Hafeez Butt COO	Chief Operating Officer	-	-

See HIGHNOON LABORATORIES LIMITED governance

Members of the board: Highnoon Laboratories Limited

Manager	Title	Age	Since
Tausif Ahmad Khan CHM	Chairman	-	83-12-31
Ghulam Hussain Khan BRD	Director/Board Member	-	88-02-29
Zainub Abbas BRD	Director/Board Member	-	00-09-02
Adeel Abbas Haideri CEO	Chief Executive Officer	-	-
Taufiq Ahmed Khan BRD	Director/Board Member	34	-
Romesh Elapata BRD	Director/Board Member	-	18-02-18
Tariq Wajid BRD	Director/Board Member	-	23-02-23

Composition of the Board of Directors

Shareholders: Highnoon Laboratories Limited

Name	Equities	%	Valuation
National Investment Trust Ltd. 1.332 %	705,982	1.332 %	2 M ₨
UBL Fund Managers Ltd. 1.136 %	601,713	1.136 %	2 M ₨
Atlas Asset Management Ltd. 0.7115 %	376,986	0.7115 %	980 216 ₨
MCB Investment Management Ltd. (Invt Mgmt) 0.5479 %	290,272	0.5479 %	754 748 ₨
Al Meezan Investment Management Ltd. 0.4577 %	242,496	0.4577 %	630 524 ₨

List of HIGHNOON LABORATORIES LIMITED shareholders

Company details: Highnoon Laboratories Limited

Highnoon Laboratories Ltd.

Tricon Corporate Centre 9th Floor Jail Road

53700, Lahore

http://www.highnoon-labs.com

address Highnoon Laboratories Limited(HINOON)

Other Pharmaceuticals

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
HIGHNOON LABORATORIES LIMITED	+0.16%	-0.41%	+102.58%	+52.47%	133M
ELI LILLY AND COMPANY	+2.18%	-2.69%	+54.63%	+284.51%	829B
NOVO NORDISK A/S	+3.18%	+3.80%	+34.82%	+191.82%	583B
JOHNSON & JOHNSON	-1.53%	-1.52%	+1.33%	-1.29%	397B
ABBVIE INC.	-2.39%	-1.23%	+30.56%	+82.41%	344B
MERCK & CO., INC.	-0.54%	-0.94%	+5.63%	+56.17%	291B
ROCHE HOLDING AG	-3.33%	-6.23%	+1.71%	-24.19%	255B
ASTRAZENECA PLC	-0.64%	-2.54%	+14.40%	+50.93%	248B
NOVARTIS AG	+0.94%	-0.61%	+9.64%	+25.08%	232B
AMGEN INC.	+0.32%	-0.20%	+26.08%	+54.38%	177B
Average	+0.10%	-2.06%	+28.14%	+77.23%	335.64B
Weighted average by Cap.	+0.33%	-2.27%	+26.56%	+123.28%